ERBB2 and non-small cell lung carcinoma: The frequency of HER2 overexpression and HER2 gene amplification in NSCLC varies significantly from one study to another, but the majority of authors agree that overexpression and amplification are most prevalent in adenocarcinomas as compared to other histological types.